Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G Palumbo

Showing results (211-220 of 218) with videos related to

Pageof 22
Sort By:
You have reached the last page of results.This site can display upto 218 results.
Annales De Biologie Clinique|January 1, 1996
Human thyroglobulin reference material (CRM 457). 2nd Part: Physicochemical characterization and certificationU Feldt-Rasmussen, C Profilis, E Colinet, et al.
Maturitas|August 23, 2002
Assessment of the QoL in Italian menopausal women: comparison between HRT users and non-usersA R Genazzani, A Nicolucci, C Campagnoli, et al.
Leukemia Research|February 1, 2015
"Real world" outcome of lenalidomide plus dexamethasone in the setting of recurrent and refractory multiple myeloma: extended follow-up of a retrospective multicenter study by the "rete ematologica pugliese"G Mele, A Melpignano, G Quarta, et al.
Climacteric : the Journal of the International Menopause Society|April 27, 2002
Validation of Italian version of the Women's Health Questionnaire: assessment of quality of life of women from the general population and those attending menopause centersA R Genazzani, A Nicolucci, C Campagnoli, et al.
Journal of Human Hypertension|June 22, 2012
Prospective appraisal of the prevalence of primary aldosteronism in hypertensive patients presenting with atrial flutter or fibrillation (PAPPHY Study): rationale and study designG P Rossi, T M Seccia, V Gallina, et al.
ESMO Open|January 8, 2025
Outcomes and prognostic indicators in daratumumab-refractory multiple myeloma: a multicenter real-world study of elotuzumab, pomalidomide, and dexamethasone in 247 patientsE A Martino, S Palmieri, M Galli, et al.
Climacteric : the Journal of the International Menopause Society|January 7, 2006
Risk factors for type 2 diabetes in women attending menopause clinics in Italy: a cross-sectional studyP Di Donato, N A Giulini, A Bacchi Modena, et al.
Maturitas|November 1, 2005
Factors associated with climacteric symptoms in women around menopause attending menopause clinics in ItalyP Di Donato, N A Giulini, A Bacchi Modena, et al.
Pageof 22

Showing results (211-220 of 218) with videos related to

Sort By:
Pageof 22
You have reached the last page of results.This site can display upto 218 results.
Annales De Biologie Clinique|January 1, 1996
Human thyroglobulin reference material (CRM 457). 2nd Part: Physicochemical characterization and certificationU Feldt-Rasmussen, C Profilis, E Colinet, et al.
Maturitas|August 23, 2002
Assessment of the QoL in Italian menopausal women: comparison between HRT users and non-usersA R Genazzani, A Nicolucci, C Campagnoli, et al.
Leukemia Research|February 1, 2015
"Real world" outcome of lenalidomide plus dexamethasone in the setting of recurrent and refractory multiple myeloma: extended follow-up of a retrospective multicenter study by the "rete ematologica pugliese"G Mele, A Melpignano, G Quarta, et al.
Climacteric : the Journal of the International Menopause Society|April 27, 2002
Validation of Italian version of the Women's Health Questionnaire: assessment of quality of life of women from the general population and those attending menopause centersA R Genazzani, A Nicolucci, C Campagnoli, et al.
Journal of Human Hypertension|June 22, 2012
Prospective appraisal of the prevalence of primary aldosteronism in hypertensive patients presenting with atrial flutter or fibrillation (PAPPHY Study): rationale and study designG P Rossi, T M Seccia, V Gallina, et al.
ESMO Open|January 8, 2025
Outcomes and prognostic indicators in daratumumab-refractory multiple myeloma: a multicenter real-world study of elotuzumab, pomalidomide, and dexamethasone in 247 patientsE A Martino, S Palmieri, M Galli, et al.
Climacteric : the Journal of the International Menopause Society|January 7, 2006
Risk factors for type 2 diabetes in women attending menopause clinics in Italy: a cross-sectional studyP Di Donato, N A Giulini, A Bacchi Modena, et al.
Maturitas|November 1, 2005
Factors associated with climacteric symptoms in women around menopause attending menopause clinics in ItalyP Di Donato, N A Giulini, A Bacchi Modena, et al.
Pageof 22